Oncology Care Model

Elsevier Needs Assessment Survey: Oncology Care Model

Under the bipartisan Medicare and CHIP Reauthorization Act of 2015, the Center for Medicare & Medicaid Innovation (CMS Innovation Center) has developed Alternative Payment Models (APMs) designed to improve the effectiveness and efficiency of specialty care. Among those specialty models is the Oncology Care Model (OCM), which aims to provide higher quality, better coordinated oncology care at the same or lower cost to Medicare.

On July 1 of 2016, the OCM was rolled out to 195 oncology clinics across the US, entering these oncology practices into payment models that include financial and performance accountability for episodes of care surrounding chemotherapy administration to cancer patients. The practices participating in OCM have committed to providing enhanced services to Medicare beneficiaries such as improved care coordination, navigation, and national treatment guidelines for care.

Please select the answer that best describes your agreement with the question regarding education. *

1 = Unlikely; 5 = Highly Likely

	1	2	3	4	5
Would you participate in a CME Conference that focuses on managing cancer patients within the Oncology Care Model?	Would you participate in a CME Conference that focuses on managing cancer patients within the Oncology Care Model? - 1	Would you participate in a CME Conference that focuses on managing cancer patients within the Oncology Care Model? - 2	Would you participate in a CME Conference that focuses on managing cancer patients within the Oncology Care Model? - 3	Would you participate in a CME Conference that focuses on managing cancer patients within the Oncology Care Model? - 4	Would you participate in a CME Conference that focuses on managing cancer patients within the Oncology Care Model? - 5

Demographic Questions

General Assessment Questions

Attitude Questions

The objective of the OCM is to reengineer the oncology patient experience to provide better care, smarter spending and healthier people.

On a scale of 1 to 5 with 5 being the most important, how would you rate the following drivers in importance to the achievement of continuous improvement driven by data? *

1 = not important; 5 = Extremely Important

	1	2	3	4	5
Data-driven quality improvement	Data-driven quality improvement - 1	Data-driven quality improvement - 2	Data-driven quality improvement - 3	Data-driven quality improvement - 4	Data-driven quality improvement - 5
Regular team meetings to review data	Regular team meetings to review data - 1	Regular team meetings to review data - 2	Regular team meetings to review data - 3	Regular team meetings to review data - 4	Regular team meetings to review data - 5
Clinical decision support system	Clinical decision support system - 1	Clinical decision support system - 2	Clinical decision support system - 3	Clinical decision support system - 4	Clinical decision support system - 5
Nationally recognized clinical guidelines	Nationally recognized clinical guidelines - 1	Nationally recognized clinical guidelines - 2	Nationally recognized clinical guidelines - 3	Nationally recognized clinical guidelines - 4	Nationally recognized clinical guidelines - 5
Team resources e.g. access to a pathology lab for molecular testing	Team resources e.g. access to a pathology lab for molecular testing - 1	Team resources e.g. access to a pathology lab for molecular testing - 2	Team resources e.g. access to a pathology lab for molecular testing - 3	Team resources e.g. access to a pathology lab for molecular testing - 4	Team resources e.g. access to a pathology lab for molecular testing - 5
Patient clinical trial opportunities	Patient clinical trial opportunities - 1	Patient clinical trial opportunities - 2	Patient clinical trial opportunities - 3	Patient clinical trial opportunities - 4	Patient clinical trial opportunities - 5

Please select the answer that best describes your agreement with each statement regarding quality measures. *

1 = Strongly Disagree; 5 = Strongly Agree

	1	2	3	4	5
I am aware of quality measures (e.g. ASCO, QOPI, PQRS, AMA, OCM, NCCN)	I am aware of quality measures (e.g. ASCO, QOPI, PQRS, AMA, OCM, NCCN) - 1	I am aware of quality measures (e.g. ASCO, QOPI, PQRS, AMA, OCM, NCCN) - 2	I am aware of quality measures (e.g. ASCO, QOPI, PQRS, AMA, OCM, NCCN) - 3	I am aware of quality measures (e.g. ASCO, QOPI, PQRS, AMA, OCM, NCCN) - 4	I am aware of quality measures (e.g. ASCO, QOPI, PQRS, AMA, OCM, NCCN) - 5
I am familiar with the National Quality Strategy priorities	I am familiar with the National Quality Strategy priorities - 1	I am familiar with the National Quality Strategy priorities - 2	I am familiar with the National Quality Strategy priorities - 3	I am familiar with the National Quality Strategy priorities - 4	I am familiar with the National Quality Strategy priorities - 5
I know where to access lists of oncology-specific quality measures	I know where to access lists of oncology-specific quality measures - 1	I know where to access lists of oncology-specific quality measures - 2	I know where to access lists of oncology-specific quality measures - 3	I know where to access lists of oncology-specific quality measures - 4	I know where to access lists of oncology-specific quality measures - 5
I do not know how to use the measures	I do not know how to use the measures - 1	I do not know how to use the measures - 2	I do not know how to use the measures - 3	I do not know how to use the measures - 4	I do not know how to use the measures - 5
I do not believe quality measures should be linked to physician payment	I do not believe quality measures should be linked to physician payment - 1	I do not believe quality measures should be linked to physician payment - 2	I do not believe quality measures should be linked to physician payment - 3	I do not believe quality measures should be linked to physician payment - 4	I do not believe quality measures should be linked to physician payment - 5
I am unsure of how to report quality measures	I am unsure of how to report quality measures - 1	I am unsure of how to report quality measures - 2	I am unsure of how to report quality measures - 3	I am unsure of how to report quality measures - 4	I am unsure of how to report quality measures - 5
Quality measures are too complicated to implement	Quality measures are too complicated to implement - 1	Quality measures are too complicated to implement - 2	Quality measures are too complicated to implement - 3	Quality measures are too complicated to implement - 4	Quality measures are too complicated to implement - 5

Please check all the items that you perceive as barriers to integrating quality improvement into practice. *

Incorporation of updated guidelines into practice

Patient adherence/compliance

Side-effect management

Access to resources

Access to treatment

Access to clinical trials

EMR system limitations

Other

Please check all the items that you perceive as barriers to integrating quality improvement into practice. Other

If you are interested in participating in the raffle for a $100 Amazon gift card, please fill out the following:

First Name:

Last Name:

Email:

Leave this field blank

You are here